FGFR2 and neoplasm: Next, we examined in vivo tumor growth and tumor angiogenesis by inoculating various combinations of Mock, VEGFR2-Fc–expressing, or FGFR2-Fc–expressing tumor cells into syngeneic mice (Fig. 4c,d) in Renca and B16F10 models.